期刊文献+

高压氧治疗及预处理变应性血管炎临床疗效分析 被引量:2

Clinical Analysis on Curative Effect of Hyperbaric Oxygen Comprehensiveness Cures and Pretreatment on Patients with Allergic Vasculitis
下载PDF
导出
摘要 目的探讨高压氧(HBO)治疗及预处理变应性血管炎的机制及临床疗效。方法回顾性分析2001—2008年46例变应性血管炎的临床资料,对其在常规治疗的基础上用HBO治疗及预处理的临床效果进行总结分析。结果经高压氧综合治疗及预处理后随访发现有64%的患者获得完全缓解。结论高压氧治疗及预处理变应性血管炎疗效显著。 Objective To discuss the mechanism and clinical effect of hyperbaric oxygen(HBO) comprehensiveness cures and pretreatment on allergic vasculitis (AV).Methods 46 cases of allergic vasculitis were reviewed retrospectively from 2001 to 2008.The treatment methods,curative effects and prevention wereStudied. Results After HBO comprehensiveness cures and pretreatment and in the follow-up,64% of patients had complete recovery. Conclusion HBO comprehensiveness cures and pretreatment have notable effects on allergic vasculitis.
作者 查晓冰
出处 《临床军医杂志》 CAS 2009年第5期844-845,共2页 Clinical Journal of Medical Officers
关键词 高压氧 预处理 变应性血管炎 hyperbaric oxygen pretreatment allergic vasculitis
  • 相关文献

参考文献5

  • 1Sams WM Jr. Necrotizing vasculitis [ J ]. J Am Acad Dcrmatol, 1980, 3(1): 1-13. 被引量:1
  • 2Hunder GG, Arend WP, Bloeh DA, et al. The American college of rheumatology 1990 criteria for the classification of vasculitis [ J ]. Arthritis Rheum, 1990,33 ( 8 ) : 1065 - 1067. 被引量:1
  • 3郭庆,罗益金,曾凡钦,翁伟丽.变应性血管炎41例临床分析[J].中国实用医药,2008,3(28):5-6. 被引量:10
  • 4牵温仁,倪国坛.高压氧医学[M].上海:上海科学技术出版社.1998.93. 被引量:1
  • 5Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium [ J ]. Circulation, 1986,74 (5) :1124 - 1136. 被引量:1

二级参考文献10

  • 1[1]Sams WM Jr.Necrotizing vasculitis.J Am Acad Dermatol,1980,3(1):1-13. 被引量:1
  • 2[2]Hunder GG,Arend WP,Bloch DA,et al.The American College of Rheumatology 1990 criteria for the classification of vasculitis.Arthritis Rheum,1990,33(8):1065-1067. 被引量:1
  • 3[3]Garcfa-porrua C,Gonzalez-Gay MA.Comparative clinical and epidemiological study of Hypersensitivity vasculitis versus Henoch-Schoenlein Purpura in adults.Seminars in Arthritis and Rheumatism,1999,28(6):404-412. 被引量:1
  • 4[4]Jennette JC,Falk RP,Andrassy K,et al.Nomenclature of systemic vasculitides:Proposal of an international consensus conference.Arthritis Rheum,1994,37(2):187-192. 被引量:1
  • 5[5]Sunderkotter C,Sindrilaru A.Clinical classification of vasculitis.Eur J Dermatol,2006,16(2):114-124. 被引量:1
  • 6[6]Michel BA,Hunder GG,Bloch DA,et al.Hypersensitivity vasculitis and Henoch-Schoenlein Purpura:A comparison between the 2 disorders.J Rheumatol,1992,19(5):721-728. 被引量:1
  • 7[7]Ekenstam EA,Callen JP.Cutaneous leukocytoclastic vasculitis.Clinical and laboratory features of 82 patients seen in private practice.Arch Dermatol,1984,120(4):484-489. 被引量:1
  • 8[8]Martinez-Taboada VM,Blanco R,Garcia-fuentes M.Clinical features and outcomes of 95 patients with hypersensitivity vasculitis.Am J Med,1997,102(2):186-191. 被引量:1
  • 9[9]Garcfa-Porrua C,Llorca J,Gonzalez-Louzao C,et al.Hypersensitivity vasculitis in adults:A benign disease usually limited to skin.Clin and Exper Rheumatol,2001,19(1):85-88. 被引量:1
  • 10[10]Sais G,Vidaller A,Jucgla A,et al.Prognostic factor in leukocytoclastic vasculitis.A clinicopathologic study of 160 patients.Arch Dermatol,1998,134(2):309-315. 被引量:1

共引文献9

同被引文献42

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部